Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2021 16:01 ET | Source: iCAD, Inc.

iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28

NASHUA, N.H., April 20, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
April 19, 2021 08:00 ET | Source: iCAD, Inc.

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

NASHUA, N.H., April 19, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that new...
April 05, 2021 16:01 ET | Source: iCAD, Inc.

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

Company expects preliminary estimated revenues to exceed $8.1 million Successor CFO search underway NASHUA, N.H., April 05, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical...
March 31, 2021 08:00 ET | Source: iCAD, Inc.

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

NASHUA, N.H., March 31, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
March 15, 2021 18:04 ET | Source: iCAD, Inc.

iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography

Company’s third generation AI solution offers significant improvement in algorithm specificity performance and faster processing compared to previous versions of the software Deep learning technology...
March 08, 2021 12:36 ET | Source: iCAD, Inc.

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

Company showcased expanded ProFound AI platform, including ProFound AI Risk, the world’s first clinical decision support tool that provides a highly accurate short-term risk estimation specific to...
March 08, 2021 08:00 ET | Source: iCAD, Inc.

iCAD Announces Closing of $25.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NASHUA, N.H., March 08, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today...
March 03, 2021 21:16 ET | Source: iCAD, Inc.

iCAD to Participate in the Cowen 41st Annual Health Care Conference

NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
March 03, 2021 00:47 ET | Source: iCAD, Inc.

iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock

NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today...
March 02, 2021 16:01 ET | Source: iCAD, Inc.

iCAD Announces Proposed Public Offering of Common Stock

NASHUA, N.H., March 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today...